Efficacy and tolerability of low-dose interferon-α in hemodialysis patients with chronic hepatitis C virus infection

Table 2 Patient treatment results

Case	IFN-αtype	HCV RNA (IU/mL)
		12 wk	48 wk	72 wk	96 wk	144 wk
1	PegIFNα-2a	405100	Positive	Positive	Positive	Positive
2	PegIFNα-2a	Negative	Negative	Negative
3	PegIFNα-2a	Negative	Negative	Negative	Negative	Negative
4	PegIFNα-2a	Negative	Negative	Negative	Negative	Negative
5	PegIFNα-2a	Negative	Negative	Negative	Negative
6	PegIFNα-2a	Negative	Negative	Negative	Negative
7	PegIFNα-2a	2380	Negative	Negative	Negative
8	PegIFNα-2a	Negative	Negative	Negative	Negative
9	PegIFNα-2a	Negative	Negative	Negative
10	PegIFNα-2a	Negative	Negative	Negative	Negative
11	PegIFNα-2a	Negative	Negative	Negative	Negative
12	PegIFNα-2a	Negative	Negative	Negative	Negative
13	IFNα-2b	Negative	Negative	Negative
14	IFNα-2b	Negative	Negative	Negative	Negative
15	IFNα-2b	Negative	Negative	Negative	Negative
16	IFNα-2b	256000	Positive	Positive
17	IFNα-2b	Negative	Negative	Negative
18	IFNα-2b	Negative	Negative	Negative
19	IFNα-2b	Negative	Positive	Positive

IFN: Interferon; PEG-IFN: Pegylated interferon; HCV: Hepatitis C virus.